RT Conference Proceedings
T1 Long-term prediction of clinical outcomes by the 21-gene test in HR+HER2-breast cancer patients with residual disease after neoadjuvant chemotherapy
A1 Peg, V.
A1 de los Angeles, N.
A1 Vieites, B.
A1 Bellet, M.
A1 Castilla, C.
A1 Gomez Pardo, P.
A1 Perez-Luque, A.
A1 Lopez, M. A.
A1 Salvador Bofill, F. J.
A1 Alfaro, L.
A1 Perez Garcia, J. M.
A1 Espinosa-Bravo, M.
PB Elsevier
SN 0923-7534
YR 2022
FD 2022-05-05
LK http://hdl.handle.net/10668/21903
UL http://hdl.handle.net/10668/21903
LA en
DS RISalud
RD Apr 12, 2025